300
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Methodological Quality of PROMs in Psychosocial Consequences of Colorectal Cancer Screening: A Systematic Review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 31-47 | Received 20 Oct 2022, Accepted 18 Feb 2023, Published online: 14 Mar 2023

References

  • Krogsgaard MR, Brodersen J, Christensen KB, et al. What is a PROM and why do we need it? Scand J Med Sci Sports. 2021;31(5):967–971. doi:10.1111/sms.13892
  • Johnston B, Patrick D, Devji D, et al. Patient-reported outcomes. In: Cochrane Handbook for Systematic Reviews of Interventions. Wiley Online Library; 2019.
  • Brodersen J, McKenna S, Doward L, Thorsen H. Measuring the psychosocial consequences of screening. Commentary. Health Qual Life Outcomes. 2007;5(1). doi:10.1186/1477-7525-5-3
  • Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11(2):106–115. doi:10.1370/afm.1466
  • Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health. 2010;13(5):601–612. doi:10.1111/j.1524-4733.2010.00697.x
  • Damhus CS, Siersma V, Hansson A, Bang CW, Brodersen J. Psychosocial consequences of screening-detected abdominal aortic aneurisms: a cross-sectional study. Scand J Prim Health Care. 2021;39(4):459–465. doi:10.1080/02813432.2021.2004713
  • Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen. 1994;1(1):7–12. doi:10.1177/096914139400100104
  • Hansen CF, Jensen J, Brodersen J, Siersma V, Comins JD, Krogsgaard MR. Are adequate PROMs used as outcomes in randomized controlled trials? An analysis of 54 trials. Scand J Med Sci Sports. 2021;31(5):972–981. doi:10.1111/sms.13896
  • Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expect. 2021;24(4):1015–1024. doi:10.1111/hex.13254
  • Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56(1):52–60. doi:10.1016/S0895-4356(02)00537-1
  • Krogsgaard MR, Brodersen J, Jensen J, Hansen CF, Comins JD. Potential problems in the use of patient reported outcome measures (PROMs) and reporting of PROM data in sports science. Scand J Med Sci Sports. 2021;31(6):1249–1258. doi:10.1111/sms.13888
  • Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen. 2004;11:39–44. doi:10.1177/096914130301100109
  • Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):5. doi:10.1186/s12874-017-0468-4
  • The National Health Service (NHS). NHS screening. Available from: https://www.nhs.uk/conditions/nhs-screening/. Accessed August 31, 2022.
  • Mokkink LB, de Vet HC, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171–1179. doi:10.1007/s11136-017-1765-4
  • Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157. doi:10.1007/s11136-018-1798-3
  • Bombardier C, Tugwell P. Methodological considerations in functional assessment. J Rheumatol. 1987;14(Suppl 15):6–10.
  • Alrubaiy L, Hutchings HA, Williams JG. Assessing patient reported outcome measures: a practical guide for gastroenterologists. United Eur Gastroenterol J. 2014;2(6):463–470. doi:10.1177/2050640614558345
  • Streiner D. A checklist for evaluating the usefulness of rating scale. Can J Psychiatry. 1993;38(2):140–148. doi:10.1177/070674379303800214
  • Gram EG, Malmqvist J, Agerbeck A, Martiny F, Bie AK, Brodersen JB. Psychosocial consequences of colorectal cancer screening in the general population: a systematic review on the adequacy of measurement properties (CRD42016051608). PROSPERO; 2022. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=51608&VersionID=1300958. Accessed March 2, 2023.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
  • Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745. doi:10.1016/j.jclinepi.2010.02.006
  • Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159–1170. doi:10.1007/s11136-018-1829-0
  • Barr PJ, Elwyn G. Measurement challenges in shared decision making: putting the ‘patient’ in patient-reported measures. Health Expect. 2016;19(5):993–1001. doi:10.1111/hex.12380
  • Wiering B, de Boer D, Delnoij D. Patient involvement in the development of patient‐reported outcome measures: a scoping review. Health Expect. 2017;20(1):11–23. doi:10.1111/hex.12442
  • McKenna SP, Heaney A. Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists? J Med Econ. 2021;24(1):502–511. doi:10.1080/13696998.2021.1907092
  • Alexander F, Weller D, Orbell S, et al. Evaluation of the UK colorectal cancer screening pilot - final report; 2003.
  • Bobridge A, Young G, Lewis H, Cole S, Bampton P. Does participating in the national bowel cancer screening program have a psychological impact? 2011.
  • Bobridge A, Bampton P, Cole S, Lewis H, Young G. The psychological impact of participating in colorectal cancer screening by faecal immuno-chemical testing--the Australian experience. Br J Cancer. 2014;111(5):970–975. doi:10.1038/bjc.2014.371
  • Brasso K, Ladelund S, Frederiksen BL, Jorgensen T. Psychological distress following fecal occult blood test in colorectal cancer screening--a population-based study. Scand J Gastroenterol. 2010;45(10):1211–1216. doi:10.3109/00365521.2010.485355
  • Chiu HC, Hung HY, Lin HC, Chen SC. Effects of a health education and telephone counseling program on patients with a positive fecal occult blood test result for colorectal cancer screening: a randomized controlled trial. Psychooncology. 2017;26(10):1498–1504. doi:10.1002/pon.4319
  • Christy SM, Schmidt A, Wang HL, et al. Understanding cancer worry among patients in a community clinic-based colorectal cancer screening intervention study. Nurs Res. 2018;67(4):275–285. doi:10.1097/NNR.0000000000000275
  • Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E. FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy. Support Care Cancer. 2013;21(10):2809–2815. doi:10.1007/s00520-013-1867-7
  • de Wijkerslooth TR, de Haan M, Stoop E, et al. Study protocol- population screening for colorectal cancer by colonoscopy or CT colonography - a randomized controlled trial. BMC Gastroenterol. 2010;10(47). doi:10.1186/1471-230X-10-47
  • de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut. 2012;61(11):1552. doi:10.1136/gutjnl-2011-301308
  • Hagger MS, Orbell S. Illness representations and emotion in people with abnormal screening results. Psychol Health. 2006;21(2):183–209. doi:10.1080/14768320500223339
  • Kapidzic A, Korfage IJ, van Dam L, et al. Quality of life in participants of a CRC screening program. Br J Cancer. 2012;107(8):1295–1301. doi:10.1038/bjc.2012.386
  • Kirkoen B, Berstad P, Botteri E, et al. Do no harm: no psychological harm from colorectal cancer screening. Br J Cancer. 2016;114(5):497–504. doi:10.1038/bjc.2016.14
  • Kirkoen B, Berstad P, Botteri E, et al. Psychological effects of colorectal cancer screening: participants vs individuals not invited. World J Gastroenterol. 2016;22(43):9631–9641. doi:10.3748/wjg.v22.i43.9631
  • Laing SS, Bogart A, Chubak J, Fuller S, Green BB. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014;23(1):154–159. doi:10.1158/1055-9965.EPI-13-0722
  • Lindholm E, Berglund B, Kewenter J, Haglind E. Worry associated with screening for colorectal carcinomas. Scand J Gastroenterol. 1997;32(3):238–245. doi:10.3109/00365529709000201
  • Malmqvist J, Siersma V, Bang CW, Brodersen J. Consequences of screening in colorectal cancer (COS-CRC): development and dimensionality of a questionnaire. BMC Psychol. 2021;9(1). doi:10.1186/s40359-020-00504-3
  • Malmqvist J, Siersma VD, Hestbech MS, Bang CW, Nicolaisdottir DR, Brodersen J. Short and long-term psychosocial consequences of participating in a colorectal cancer screening programme: a matched longitudinal study. BMJ Evid Based Med. 2022;27(2):87–96. doi:10.1136/bmjebm-2020-111576
  • Malmqvist J, Siersma V, Hestbech MS, Nicolaisdottir DR, Bang CW, Brodersen J. Psychosocial consequences of invitation to colorectal cancer screening: a matched cohort study. J Epidemiol Community Health. 2021;75(9):867–873. doi:10.1136/jech-2019-213360
  • Miles A, Wardle J. Adverse psychological outcomes in colorectal cancer screening: does health anxiety play a role? Behav Res Ther. 2006;44(8):1117–1127. doi:10.1016/j.brat.2005.08.011
  • Miles A, Atkin WS, Kralj-Hans I, Wardle J. The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy. J Med Screen. 2009;16(3):124–130. doi:10.1258/jms.2009.009041
  • Miles A, McClements PL, Steele RJ, Redeker C, Sevdalis N, Wardle J. The psychological impact of a colorectal cancer diagnosis following a negative fecal occult blood test result. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1032–1038. doi:10.1158/1055-9965.EPI-15-0004
  • Mountifield RE, Bampton PA, Prosser R, Bobridge A, Mikocka-Walus AA, Andrews JM. Mo1962 FIT+ and IBD individuals have differing psychological reactions to the need for colonoscopy. Gastroenterology. 2013;144(5):S705. doi:10.1016/S0016-5085(13)62614-1
  • Mountifield RE, Moseley A, Prosser R, et al. Colonoscopic bowel cancer screening is associated with more depression and anxiety in previously healthy people than those with inflammatory bowel disease. Gastroenterology. 2011;140(5):S433. doi:10.1016/s0016-5085(11)61777-0
  • Orbell S, O’Sullivan I, Parker R, Steele B, Campbell C, Weller D. Illness representations and coping following an abnormal colorectal cancer screening result. Soc Sci Med. 2008;67(9):1465–1474. doi:10.1016/j.socscimed.2008.06.039
  • Parker MA, Robinson MH, Scholefield JH, Hardcastle JD. Psychiatric morbidity and screening for colorectal cancer. J MedScreen. 2002;9:7–10. doi:10.1136/jms.9.1.7
  • Robb KA, Lo SH, Power E, et al. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK. J Med Screen. 2012;19(4):171–176. doi:10.1258/jms.2012.012129
  • Sharp L, Shearer N, Leen R, O’Morain C, McNamara D. Prevalence and predictors of colonoscopy-related distress in individuals undergoing fit-based colorectal cancer screening: a population-based study. Presented at: the Irish Society of Gastroenterology Winter Meeting, November 2013; 2015: The Malton Hotel, Killarney, Co. Kerry. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25686788. Accessed March 2, 2023.
  • Simon AE, Steptoe A, Wardle J. Socioeconomic status differences in coping with a stressful medical procedure. Psychosom Med. 2005;67(2):270–276. doi:10.1097/01.psy.0000155665.55439.53
  • Thiis-Evensen E, Wilhelmsen I, Hoff GS, Blomhoff S, Sauar J. The psychologic effect of attending a screening program for colorectal polyps. Scand J Gastroenterol. 1999;34(1):103–109. doi:10.1080/00365529950172916
  • Taupin D, Chambers SL, Corbett M, Shadbolt B. Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study. Health Qual Life Outcomes. 2006;4(1):82. doi:10.1186/1477-7525-4-82
  • Tutein Nolthenius CJ, Boellaard TN, de Haan MC, et al. Burden of waiting for surveillance CT colonography in patients with screen-detected 6–9 mm polyps. Eur Radiol. 2016;26(11):4000–4010. doi:10.1007/s00330-016-4251-4
  • van Dam L, de Wijkerslooth TR, de Haan MC, et al. Time requirements and health effects of participation in colorectal cancer screening with colonoscopy or computed tomography colonography in a randomized controlled trial. Endoscopy. 2013;45(3):182–188. doi:10.1055/s-0032-1326080
  • Vermeer NCA, van der Valk MJM, Snijders HS, et al. Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening. Psychooncology. 2020;29(6):1084–1091. doi:10.1002/pon.5381
  • Wardle J, Williamson S, Sutton S, et al. Psychological impact of colorectal cancer screening. Health Psychol. 2003;22(1):54–59. doi:10.1037/0278-6133.22.1.54
  • Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012
  • Alper BS, Oettgen P, Kunnamo I, et al. Defining certainty of net benefit: a GRADE concept paper. BMJ Open. 2019;9(6):e027445. doi:10.1136/bmjopen-2018-027445
  • Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (Rockv). 2013;17(13). doi:10.3310/hta17130
  • DeFrank JT, Barclay C, Sheridan S, et al. The psychological harms of screening: the evidence we have versus the evidence we need. J Gen Intern Med. 2015;30(2):242–248. doi:10.1007/s11606-014-2996-5
  • Heiberg Agerbeck A, Martiny FHJ, Jauernik CP, et al. Validity of current assessment tools aiming to measure the affective component of pain: a systematic review. Patient Relat Outcome Meas. 2021;12:213–226. doi:10.2147/PROM.S304950
  • DeFrank J, Brewer NT. Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results. Evid Based Med. 2014;19(1):38. doi:10.1136/eb-2013-101409
  • Hobart JC, Williams LS, Moran K, Thompson AJ. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke. 2002;33(5):1348–1356. doi:10.1161/01.STR.0000015030.59594.B3
  • Entwistle VA, Skea ZC, O’Donnell MT. Decisions about treatment: interpretations of two measures of control by women having a hysterectomy. Soc Sci Med. 2001;53(6):721–732. doi:10.1016/S0277-9536(00)00382-8
  • Davey HM, Lim J, Butow PN, Barratt AL, Redman S. Women’s preferences for and views on decision-making for diagnostic tests. Soc Sci Med. 2004;58(9):1699–1707. doi:10.1016/S0277-9536(03)00339-3
  • van der Velde JL, Blanker MH, Stegmann ME, de Bock GH, Berger MY, Berendsen AJ. A systematic review of the psychological impact of false-positive colorectal cancer screening: what is the role of the general practitioner? Eur J Cancer Care (Engl). 2017;26(3):e12709. doi:10.1111/ecc.12709
  • Chad-Friedman E, Coleman S, Traeger LN, et al. Psychological distress associated with cancer screening: a systematic review. Cancer. 2017;123(20):3882–3894. doi:10.1002/cncr.30904
  • Selva A, Selva C, Alvarez-Perez Y, et al. Satisfaction and experience with colorectal cancer screening: a systematic review of validated patient reported outcome measures. BMC Med Res Methodol. 2021;21(1):230. doi:10.1186/s12874-021-01430-7
  • Brodersen J, Thorsen H. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Public Health. 2008;26:251–256. doi:10.1080/02813430802542508
  • Birney DP, Beckmann JF, Beckmann N, Stemler SE. Sophisticated statistics cannot compensate for method effects if quantifiable structure is compromised. Front Psychol. 2022;13:812963. doi:10.3389/fpsyg.2022.812963